Tatsuo Suda Selected Research

Bone Resorption

1/2018	Mechanisms involved in bone resorption regulated by vitamin D.
6/2017	VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
9/2015	Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase.
1/2014	Vitamin D: calcium and bone homeostasis during evolution.
1/2014	Vitamin D endocrine system and osteoclasts.
7/2012	Bone effects of vitamin D - Discrepancies between in vivo and in vitro studies.
2/2012	Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
12/2005	Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
10/2003	In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
2/2003	Vitamin D and bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tatsuo Suda Research Topics

Disease

10	Bone Resorption 01/2018 - 02/2003
8	Osteoporosis 01/2019 - 02/2003
1	Chronic Renal Insufficiency 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 09/2015
1	Rickets (Rachitis) 01/2014
1	Bone Fractures (Bone Fracture) 07/2012
1	Body Weight (Weight, Body) 02/2012
1	Hypercalcemia (Milk Alkali Syndrome) 02/2012
1	Renal Insufficiency (Renal Failure) 04/2003
1	Nephritis 04/2003
1	Albuminuria 04/2003
1	Hyperlipidemias (Hyperlipidemia) 04/2003
1	Metabolic Bone Diseases (Osteopenia) 02/2003
1	Secondary Hyperparathyroidism 02/2003
1	Neoplasms (Cancer) 03/2002
1	Rheumatoid Arthritis 02/2002

Drug/Important Bio-Agent (IBA)

6	hydroxide ionIBA 01/2019 - 02/2003
6	Vitamin D FDA LinkGeneric 01/2018 - 10/2003
3	eldecalcitol (ED 71)IBA 01/2014 - 02/2012
3	LigandsIBA 01/2014 - 03/2002
2	Pharmaceutical PreparationsIBA 01/2019 - 07/2012
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2014 - 01/2014
2	alfacalcidolIBA 01/2014 - 07/2012
2	VitaminsIBA 02/2012 - 10/2003
2	1,25-dihydroxyvitamin DIBA 10/2003 - 02/2003
1	AcetylcholinesteraseIBA 09/2015
1	Donepezil (Aricept)FDA LinkGeneric 09/2015
1	CalciumIBA 01/2014
1	Cholecalciferol (Vitamin D3)FDA Link 01/2014
1	ProdrugsIBA 07/2012
1	RANK LigandIBA 12/2005
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 10/2003
1	Parathyroid Hormone (Parathormone)IBA 10/2003
1	NF-kappa B (NF-kB)IBA 10/2003
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 10/2003
1	OsteoprotegerinIBA 10/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2002
1	CytokinesIBA 02/2002

Therapy/Procedure

1	Therapeutics 12/2005